Therapeutic concerns when oral medications are administered nasogastrically

Journal of Clinical Pharmacy and Therapeutics

Volumn 38, Issue 4, 2013, Pages 272-276

  Zhu, L L ^a   Zhou, Q ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

drug administration routes; nasogastric tube; rational drug use

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; BICARBONATE; CARBIDOPA PLUS LEVODOPA; CLOPIDOGREL; DULOXETINE; ESOMEPRAZOLE; LANSOPRAZOLE; NIFEDIPINE; PANTOPRAZOLE;

CLINICAL PRACTICE; CORONARY ARTERY BYPASS GRAFT; DRUG ABSORPTION; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; ENTERIC FEEDING; HUMAN; NASOGASTRIC TUBE; ORAL DRUG ADMINISTRATION; PATIENT CARE; PRESCRIPTION; REVIEW; SUSPENSION; TABLET;

DRUG ADMINISTRATION ROUTES; NASOGASTRIC TUBE; RATIONAL DRUG USE;

ABSORPTION; ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; HUMANS; INTUBATION, GASTROINTESTINAL; PHARMACEUTICAL PREPARATIONS; SUSPENSIONS;

EID: 84879976320     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12041edit     Document Type: Review

References (34)

1. Podilsky G, Berger-Gryllaki M, Testa B, Buclin T, Roulet M, Pannatier A,. The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube. Eur J Clin Pharmacol, 2009; 65: 435-442.
2. Clarke S,. Drug administration via nasogastric tube. Paediatr Nurs, 2008; 20: 32.
3. Gosgnach M, Aymard G, Huraux C, Fléron MH, Coriat P, Diquet B,. Atenolol administration via a nasogastric tube after abdominal surgery: an unreliable route. Anesth Analg, 2005; 100: 137-140.
4. Garnock-Jones KP,. Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension. Drugs, 2012; 72: 109-132.
5. Kotake T, Takada M, Goto T, Komamura K, Kamakura S, Morishita H,. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration. J Clin Pharm Ther, 2006; 31: 237-243.
6. Tisdale JE, Wroblewski HA, Hammoud ZT, Rieger KM, Young JV, Wall DS, Kesler KA, Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy. Clin Ther, 2007; 29: 2226-2234.
7. Bass J, Miles MV, Tennison MB, Holcombe BJ, Thorn MD,. Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension. Epilepsia, 1989; 30: 364-369.
8. Cohn SM, Cohn KA, Rafferty MJ, Smith AH, Degutis LC, Kowalsky SF, Shah A., Enteric absorption of ciprofloxacin during the immediate postoperative period. J Antimicrob Chemother, 1995; 36: 717-721.
9. Mimoz O, Binter V, Jacolot A, Edouard A, Tod M, Petitjean O, Samii K., Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Med, 1998; 24: 1047-1051.
10. Zafar MU, Farkouh ME, Fuster V, Chesebro JH,. Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets. J Interv Cardiol, 2009; 22: 385-389.
11. Nicolau DP, Crowe H, Nightingale CH, Quintiliani R,. Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients. J Antimicrob Chemother, 1995; 36: 395-401.
12. Rosemurgy AS, Markowsky S, Goode SE, Plastino K, Kearney RE,. Bioavailability of fluconazole in surgical intensive care unit patients: a study comparing routes of administration. J Trauma, 1995; 39: 445-447.
13. Mohammedi I, Piens MA, Padoin C, Robert D,. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients. Eur J Clin Microbiol Infect Dis, 2005; 24: 358-360.
14. Pemberton LB, Schaefer N, Goehring L, Gaddis M, Arrighi DA,. Oral ranitidine as prophylaxis for gastric stress ulcers in intensive care unit patients: serum concentrations and cost comparisons. Crit Care Med, 1993; 21: 339-342.
15. Sai Y, Kusaka A, Imanishi K, et al,. A randomized, quadruple crossover single-blind study on immediate action of chewed and unchewed low-dose acetylsalicylic acid tablets in healthy volunteers. J Pharm Sci, 2011; 100: 3884-3891.
16. Shennib H, Endo M, Benhameid O,. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting. Heart Surg Forum, 2003; 6: 288-291.
17. Sandercock PA, Counsell C, Gubitz GJ, Tseng MC., Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev, 2008; 16: CD000029.
18. Sostek MB, Chen Y, Skammer W, Winter H, Zhao J, Andersson T,. Esomeprazole administered through a nasogastric tube provides bioavailability similar to oral dosing. Aliment Pharmacol Ther, 2003; 18: 581-586.
19. Stagg P, Grice T,. Nasogastric medication for perioperative Parkinson's rigidity during anaesthesia emergence. Anaesth Intensive Care, 2011; 39: 1128-1130.
20. Wells KA, Losin WG,. In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding. Clin Ther, 2008; 30: 1300-1308.
21. Schier JG, Howland MA, Hoffman RS, Nelson LS,. Fatality from administration of labetalol and crushed extended-release nifedipine. Ann Pharmacother, 2003; 37: 1420-1423.
22. Berkovitch M, Dafni O, Leiboviz A, Mayan H, Habut B, Segal R,. Therapeutic drug monitoring of theophylline in frail elderly patients: oral compared with nasogastric tube administration. Ther Drug Monit, 2002; 24: 594-597.
23. Messaouik D, Sautou-Miranda V, Bagel-Boithias S, Chopineau J,. Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube. Int J Pharm, 2005; 299: 65-72.
24. Ponrouch MP, Sautou-Miranda V, Boyer A, Bourdeaux D, Montagner A, Chopineau J,. Proton pump inhibitor administration via nasogastric tube in pediatric practice: comparative analysis with protocol optimization. Int J Pharm, 2010; 390: 160-164.
25. Ferron GM, Ku S, Abell M, Unruh M, Getsy J, Mayer PR, Paul J., Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution. Am J Health-Syst Pharm, 2003; 60: 1324-1329.
26. Tammara B, Weisel K, Katz A, Meng X,. Bioequivalence among three methods of administering pantoprazole granules in healthy subjects. Am J Health-Syst Pharm, 2009; 66: 1923-1928.
27. Nguyen KQ, Hawkins MG, Taylor IT, Wiebe VJ, Tell LA,. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures. Am J Vet Res, 2009; 70: 908-914.
28. Skillman KL, Caruthers RL, Johnson CE,. Stability of an extemporaneously prepared clopidogrel oral suspension. Am J Health-Syst Pharm, 2010; 67: 559-561.
29. Helin-Tanninen M, Naaranlahti T, Kontra K, Ojanen T,. Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension. J Clin Pharm Ther, 2001; 26: 59-66.
30. Glass BD, Haywood A,. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. J Pharm Pharm Sci, 2006; 9: 398-426.
31. Cacek AT, DeVito JM, Koonce JR,. In vitro evaluation of nasogastric administration methods for phenytoin. Am J Hosp Pharm, 1986; 43: 689-692.
32. Chun AH, Shi HH, Achari R, Dennis S, Cavanaugh JH,. Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube. Clin Ther, 1996; 18: 833-842.
33. Bader MK,. Case study of two methods for enteral phenytoin administration. J Neurosci Nurs, 1993; 25: 233-242.
34. Cooper MK, Brock DG, McDaniel CM,. Interaction between levodopa and enteral nutrition. Ann Pharmacother, 2008; 42: 439-442.